APA (7th ed.) Citation

A, B., A, S., S, M., S, G., & JS, L. (2022). Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1). The British journal of dermatology, 187(5), e168. https://doi.org/10.1111/bjd.21654

Chicago Style (17th ed.) Citation

A, Belzer, Silber A, Mehra S, Gilani S, and Leventhal JS. "Mucosal Haemangioma in the Setting of Treatment with Trastuzumab Emtansine (T-DM1)." The British Journal of Dermatology 187, no. 5 (2022): e168. https://doi.org/10.1111/bjd.21654.

MLA (9th ed.) Citation

A, Belzer, et al. "Mucosal Haemangioma in the Setting of Treatment with Trastuzumab Emtansine (T-DM1)." The British Journal of Dermatology, vol. 187, no. 5, 2022, p. e168, https://doi.org/10.1111/bjd.21654.